Curiosity Delivers.

clinical trials

clinical trials

McGill bioethicists argue for stricter limits on first-in-human clinical trials

The standards for drugs entering first-in-human (FIH) clinical trials are too low, argues Associate Professor Dr. Jonathan Kimmelman and PhD candidate Carole Federico in McGill’s Biomedical Ethics Unit. In a commentary published online in Nature on Jan. 30, Kimmelman and Federico maintain that evidence for drug efficacy is not emphasized enough before FIH trials and call for… Keep Reading

Curiosity Delivers.
Go to Top